JP2014167010A5 - - Google Patents

Download PDF

Info

Publication number
JP2014167010A5
JP2014167010A5 JP2014090998A JP2014090998A JP2014167010A5 JP 2014167010 A5 JP2014167010 A5 JP 2014167010A5 JP 2014090998 A JP2014090998 A JP 2014090998A JP 2014090998 A JP2014090998 A JP 2014090998A JP 2014167010 A5 JP2014167010 A5 JP 2014167010A5
Authority
JP
Japan
Prior art keywords
use according
dermatophyte
infection
trichophyton
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014090998A
Other languages
English (en)
Japanese (ja)
Other versions
JP6199797B2 (ja
JP2014167010A (ja
Filing date
Publication date
Priority claimed from GBGB0526120.1A external-priority patent/GB0526120D0/en
Application filed filed Critical
Publication of JP2014167010A publication Critical patent/JP2014167010A/ja
Publication of JP2014167010A5 publication Critical patent/JP2014167010A5/ja
Application granted granted Critical
Publication of JP6199797B2 publication Critical patent/JP6199797B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014090998A 2005-12-22 2014-04-25 環状抗微生物ペプチド Expired - Fee Related JP6199797B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB0526120.1A GB0526120D0 (en) 2005-12-22 2005-12-22 Therapeutic peptides
GB0526120.1 2005-12-22
US77650506P 2006-02-24 2006-02-24
US60/776,505 2006-02-24

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2008546630A Division JP5559477B2 (ja) 2005-12-22 2006-12-21 環状抗微生物ペプチド

Publications (3)

Publication Number Publication Date
JP2014167010A JP2014167010A (ja) 2014-09-11
JP2014167010A5 true JP2014167010A5 (enExample) 2014-12-18
JP6199797B2 JP6199797B2 (ja) 2017-09-20

Family

ID=37836928

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2008546630A Active JP5559477B2 (ja) 2005-12-22 2006-12-21 環状抗微生物ペプチド
JP2012252220A Expired - Fee Related JP6050096B2 (ja) 2005-12-22 2012-11-16 環状抗微生物ペプチド
JP2014090998A Expired - Fee Related JP6199797B2 (ja) 2005-12-22 2014-04-25 環状抗微生物ペプチド

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2008546630A Active JP5559477B2 (ja) 2005-12-22 2006-12-21 環状抗微生物ペプチド
JP2012252220A Expired - Fee Related JP6050096B2 (ja) 2005-12-22 2012-11-16 環状抗微生物ペプチド

Country Status (14)

Country Link
US (2) US8324154B2 (enExample)
EP (4) EP2357190A3 (enExample)
JP (3) JP5559477B2 (enExample)
KR (1) KR101413746B1 (enExample)
AU (1) AU2006327973B2 (enExample)
CA (1) CA2655448C (enExample)
CY (1) CY1113770T1 (enExample)
IL (2) IL192373A (enExample)
MX (1) MX2008008291A (enExample)
NO (1) NO346186B1 (enExample)
PL (1) PL1976863T3 (enExample)
RU (1) RU2463308C2 (enExample)
WO (1) WO2007072037A1 (enExample)
ZA (1) ZA200806329B (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2357190A3 (en) * 2005-12-22 2011-08-24 Novabiotics Limited Cyclic antimicrobial peptides
GB0702020D0 (en) * 2007-02-02 2007-03-14 Novabiotics Ltd Peptides and their use
US20110039763A1 (en) 2009-01-06 2011-02-17 C3 Jian, Inc. Targeted antimicrobial moieties
WO2012135846A1 (en) * 2011-04-01 2012-10-04 Northeastern University Methods of eradicating bacterial cell populations
EP2794645A1 (en) * 2011-12-21 2014-10-29 Regents of the University of Minnesota Cationic peptides and use of such peptides for inhibiting exotoxin production
KR101502797B1 (ko) * 2012-08-22 2015-03-17 연세대학교 산학협력단 신규한 양친매성 고리형 펩티드, 이의 제조방법 및 이를 포함하는 안정한 자기조립 나노전달체
US9082888B2 (en) 2012-10-17 2015-07-14 New York University Inverted orthogonal spin transfer layer stack
US10815276B2 (en) 2014-05-21 2020-10-27 Entrada Therapeutics, Inc. Cell penetrating peptides and methods of making and using thereof
SMT201900441T1 (it) 2014-05-21 2019-09-09 Entrada Therapeutics Inc Peptidi che penetrano nelle cellule e metodi per la loro preparazione e per il loro uso
EP3185880B1 (en) 2014-08-27 2020-02-12 Ohio State Innovation Foundation Improved peptidyl calcineurin inhibitors
CN107614004B (zh) * 2015-03-23 2022-12-06 激流生物科学有限公司 抗微生物肽及其使用方法
KR101692992B1 (ko) 2015-05-20 2017-01-17 연세대학교 산학협력단 고리형 펩타이드의 사전 활성화 합성방법 및 이에 따라 합성된 고리형 펩타이드
US11339192B2 (en) 2017-10-04 2022-05-24 Ohio State Innovation Foundation Bicyclic peptidyl inhibitors
EP3749365A4 (en) 2018-01-29 2022-01-12 Ohio State Innovation Foundation PEPTIDY INHIBITORS OF THE CALCINEURIN-NFAT INTERACTION
WO2019165183A1 (en) 2018-02-22 2019-08-29 Entrada Therapeutics, Inc. Compositions and methods for treating mitochondrial neurogastrointestinal encephalopathy
WO2019217682A1 (en) 2018-05-09 2019-11-14 Ohio State Innovation Foundation Cyclic cell-penetrating peptides with one or more hydrophobic residues
GB202010268D0 (en) * 2020-07-03 2020-08-19 Novabiotics Ltd Nail formulations and treatment regimes
CN115716865B (zh) * 2022-11-24 2024-04-30 安徽农业大学 具有肝癌细胞毒性和α-葡萄糖苷酶抑制活性的环色-苏-酪-缬-亮肽及制备方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4051842A (en) 1975-09-15 1977-10-04 International Medical Corporation Electrode and interfacing pad for electrical physiological systems
DE2626348C3 (de) 1976-06-11 1980-01-31 Siemens Ag, 1000 Berlin Und 8000 Muenchen Implantierbare Dosiereinrichtung
US4383529A (en) 1980-11-03 1983-05-17 Wescor, Inc. Iontophoretic electrode device, method and gel insert
US4962091A (en) 1986-05-23 1990-10-09 Syntex (U.S.A.) Inc. Controlled release of macromolecular polypeptides
US5652211A (en) * 1991-02-11 1997-07-29 Biosynth S.R.L. Peptides for neutralizing the toxicity of Lipid A
CA2145093C (en) 1992-09-25 2007-04-10 Lawrence Leroy Kunz Therapeutic inhibitor of vascular smooth muscle cells
AU727085B2 (en) * 1995-07-20 2000-11-30 Xoma Corporation Anti-fungal peptides
DE19534177A1 (de) * 1995-09-15 1997-03-20 Merck Patent Gmbh Cyclische Adhäsionsinhibitoren
US5916872A (en) * 1996-07-24 1999-06-29 Intrabiotics Pharmaceuticals, Inc. Cyclic peptides having broad spectrum antimicrobial activity
US6096707A (en) * 1997-07-11 2000-08-01 Biotie Therapies Ltd. Integrin binding peptide and use thereof
US6951652B2 (en) * 1998-07-29 2005-10-04 Biosynth S.R.L. Vaccine for prevention of gram-negative bacterial infections and endotoxin related diseases
JP2004535392A (ja) * 2001-05-04 2004-11-25 ザ スクリプス リサーチ インスティチュート 抗菌ペプチドおよび組成物
US7033991B2 (en) * 2001-07-16 2006-04-25 Board Of Supervisors Of Louisiana State University And Agriculture And Mechanical College Inhibiting furin with polybasic peptides
WO2003093300A2 (en) * 2002-05-06 2003-11-13 The Scripps Research Institute Anti-microbial peptides and compositions
WO2004050685A2 (en) * 2002-11-29 2004-06-17 Adaptive Therapeutics, Inc. Antifungal therapeutic agents
US6783677B1 (en) * 2003-02-06 2004-08-31 Mayyar Systems, Inc. Anaerobic film biogas digester system
AU2004246909B2 (en) * 2003-06-19 2010-08-19 Yeda Research & Development Co. Ltd. Antimicrobial and anticancer lipopeptides
EP1778720B1 (en) * 2004-08-18 2010-09-01 Novabiotics Limited Antimicrobial peptides comprising an arginine- and/or lysine-containing motif
EP2357190A3 (en) * 2005-12-22 2011-08-24 Novabiotics Limited Cyclic antimicrobial peptides

Similar Documents

Publication Publication Date Title
JP2014167010A5 (enExample)
JP2014515013A5 (enExample)
JP2013032389A5 (enExample)
WO2013123215A3 (en) Antiviral drugs for treatment of arenavirus infection
JP2017537066A5 (enExample)
EA201790389A1 (ru) Пирролопиримидиновые соединения, используемые в качестве агониста tlr7
JP2013518107A5 (enExample)
JP2012136541A5 (enExample)
PH12018500904A1 (en) Peptide macrocycles against acinetobacter baumannii
NZ748966A (en) Functionalized benzamide derivatives as antiviral agents against hbv infection
EA201891103A1 (ru) Композиции для лечения спинальной мышечной атрофии
JP2013520405A5 (enExample)
NZ732391A (en) Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
JP2013509429A5 (enExample)
JP2014051497A5 (enExample)
JP2019516735A5 (enExample)
PH12014501937B1 (en) Pharmaceutical composition containing an antivirally active dihydroquinazoline derivative
EA032938B1 (ru) Производное глутаримидов, его применение, фармацевтическая композиция на его основе, способ его получения
AR085856A1 (es) Formas cristalinas del acido (2s)-2-ter-butoxi-2-(4-(2,3-dihidropirano[4,3,2-de]quinolin-7-il)-2-metilquinolin-3-il)acetico
EA201691538A1 (ru) Способ получения солей вортиоксетина
JP2015516419A5 (enExample)
JP2017518982A5 (enExample)
RU2017145271A (ru) Терапевтическое средство для фиброза
CN109790123A (zh) 新型衣壳蛋白装配抑制剂
JP2016532632A5 (enExample)